Deep Vein Thrombosis  
The MD Magazine Deep Vein Thrombosis condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.


Deficient Sleep Heightens Atrial Fibrillation Risk
Several studies have shown that patients with sleep apnea are more likely than others to develop atrial fibrillation, but recent information indicates that any type of disrupted sleep may indicate an elevated risk.
It is reportedly safe to use tissue plasminogen activator, the clot busting medication, on patients who wake up with symptoms of stroke, according to a new study. Generally, tPA should be administered within 4.5 hours of symptom onset to be considered effective.
Authors of a new meta-analysis of warfarin use in ESRD patients raised concerns that the anticoagulant may not lower stroke risk in these patients, and as such, might itself be an unnecessary risk.
“We found that the risk of ischemic stroke...the most common stroke subtype, is increased in overweight and obese women,” study author Gillian Reeves, explained. “By contrast, the risk of hemorrhagic decreased in overweight and obese women.
A large registry study has found that short bouts of atrial fibrillation (AF) are not associated with any adverse events and, therefore, may not require anticoagulation or any other treatment.
The new study joins previous works that have found a significant connection between ablation and improved outcomes in atrial fibrillation patients.
Although there are difference in how and to whom oral anticoagulants (OACs) are prescribed, UK researchers have found that those taking apixaban seem to have higher persistence rates.
The aim of the present meta-analysis was “to estimate the yield of AF detection in patients with stroke due to small and large vessel disease and in stroke patients in whom stroke etiology was not defined,” say the researchers.
The prevalence of vascular cognitive impairment and vascular dementia are increasing among the elderly. This presents a diagnostic problem, as about 40 percent of patients have coincident vascular cognitive disorder and Alzheimer’s disease pathologic processes

Most Popular


$vacMongoViewPlus$ $vAR$